Skip to main content
. 2018 Oct 30;11:102–108. doi: 10.1016/j.omto.2018.10.004

Figure 5.

Figure 5

Overall Survival of Metastasized Mice

Mice inoculated with DOX-resistant 4T1 cells were treated with Doxil, PEG- multifunctional envelop-type nano device (MEND) (no RGD modification), and RGD-MEND at 2.0 mg/kg (siRNA) or 3.0 mg/kg (doxorubicin) at days 1, 3, 5, 8, 11, 14, and 20 (n = 4–5).